News
Unusual fatigue or tingling could signal sclerosis. Learn the early signs, causes, and how to manage this misunderstood ...
Frank battled a degenerative disease in 'The Last of Us,' but the show never specified the name of his illness ...
Amyotrophic lateral sclerosis (ALS) is a relatively rare but very serious disease of the nervous system. A cure is not yet ...
7d
MONTCO Today on MSNHow Can Rehabilitation Therapies Help With Multiple Sclerosis?Multiple sclerosis (MS) is a chronic disease of the central nervous system that is thought to be an autoimmune disorder where ...
9d
The Hearty Soul on MSNVitamin D supplements could reduce multiple sclerosis symptoms, study suggestsMultiple sclerosis is an autoimmune condition that affects your central nervous system. The condition causes your immune system to attack the myelin cells, the protective sheaths surrounding your ...
"We hope that the tool will unlock valuable information from millions of untapped brain images that were previously difficult or impossible to understand, immediately leading to valuable insights into ...
Roxana Ehsani, MS, RD, CSSD, LDN, is a Registered Dietitian Nutritionist and Board-Certified Specialist in Sports Dietetics. She works as a media spokesperson, nutrition consultant, recipe ...
However, finding the connection was not easy. “It started with the observation that the epidemiology of multiple sclerosis is quite unique because there is a very striking geographical ...
A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.
A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses ...
on Friday, Feb. 7, 2025. (Pete Young/Bay City News) A researcher at the University of California, San Francisco was honored for transforming the understanding and treatment of multiple sclerosis, the ...
Roche has announced results from the Phase III MUSETTE clinical trial of high-dose Ocrevus (ocrelizumab) intravenous (IV) infusion in patients with relapsing multiple sclerosis (RMS). The study did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results